Crossref
Nephrotic Syndrome and Pulmonary Hypertension After Bevacizumab in a Woman with Intrahepatic Cholangiocarcinoma
Journal of the American Society of Nephrology · 2026-10 · 37 (10S)
DOI: 10.1681/asn.20263pp11cx2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Society of Nephrology, 2026-10. Verfasst von Aimei Li und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Li, A., Li, L., Zhang, D. D., & Yi, B. (2026). Nephrotic Syndrome and Pulmonary Hypertension After Bevacizumab in a Woman with Intrahepatic Cholangiocarcinoma. Journal of the American Society of Nephrology, 37(10S). https://doi.org/10.1681/asn.20263pp11cx2
Vancouver
Li A, Li L, Zhang DD, Yi B. Nephrotic Syndrome and Pulmonary Hypertension After Bevacizumab in a Woman with Intrahepatic Cholangiocarcinoma. Journal of the American Society of Nephrology. 2026;37(10S). doi:10.1681/asn.20263pp11cx2
BibTeX
@article{Li2026,
author = {Li, Aimei and Li, Ling and Zhang, Dong Dong and Yi, Bin},
title = {Nephrotic Syndrome and Pulmonary Hypertension After Bevacizumab in a Woman with Intrahepatic Cholangiocarcinoma},
journal = {Journal of the American Society of Nephrology},
year = {2026},
volume = {37},
number = {10S},
doi = {10.1681/asn.20263pp11cx2}
}
EUVIMED